Kazia Therapeutics Limited (KZIA)

Kazia Therapeutics Balance Sheet

Financials in millions AUD. Fiscal year is July - June.

Year	2023	2022	2021	2020	2019
Cash & Equivalents	5.24	7.36	27.59	8.76	5.43
Cash & Cash Equivalents	5.24	7.36	27.59	8.76	5.43
Cash Growth	-28.80%	-73.32%	214.78%	61.28%	-8.76%
Receivables	3.94	7.39	6.78	1.35	1.71
Other Current Assets	1.59	-5.3	-4.97	0.54	0.37
Total Current Assets	10.77	9.45	29.39	10.65	7.52
Long-Term Investments	0	0	0	0	0.17
Goodwill and Intangibles	17.27	19.14	21.01	12.41	13.49
Other Long-Term Assets	0.04	7.3	6.69	0	0
Total Long-Term Assets	17.31	26.44	27.7	12.41	13.66
Total Assets	28.09	35.89	57.09	23.06	21.18
Accounts Payable	4.33	3.76	4.93	3.49	1.76
Current Debt	1.8	1.84	0	0	0
Other Current Liabilities	1.44	1.13	1.02	1.58	0.14
Total Current Liabilities	7.57	6.73	5.95	5.07	1.9
Other Long-Term Liabilities	8.47	10.89	13.29	3.87	5.08
Total Long-Term Liabilities	8.47	10.89	13.29	3.87	5.08
Total Liabilities	16.03	17.61	19.24	8.94	6.98
Total Debt	1.8	1.84	0	0	0
Debt Growth	-2.42%	-	-	-	-
Retained Earnings	-89.08	-68.62	-44.2	-36.19	-24.95
Shareholders' Equity	12.05	18.28	37.85	14.13	14.2
Net Cash / Debt	3.44	5.52	27.59	8.76	5.43
Net Cash / Debt Growth	-37.60%	-79.99%	214.78%	61.28%	-8.76%
Working Capital	3.21	2.72	23.44	5.59	5.62
Book Value Per Share	0.74	1.38	4.00	2.27	2.93

Source: Financials are provided by Nasdaq Data Link and sourced from audited reports submitted to the Securities and Exchange Commission (SEC).